跳至主要内容
临床试验/TCTR20220419012
TCTR20220419012进行中(未招募)3 期

Transdermal Estrogen Provides Comparable Effectiveness with Desmopressin in Preventing Uremic Bleeding in Chronic Kidney Disease Patients Undergoing Kidney Biopsy: A Randomized, double-blinded controlled trial

Kinh Chulalongkorn memorial hospital0 个研究点目标入组 94 人开始时间: 2022年4月19日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Inclusion criteria were patients undergoing ultrasound-guided kidney biopsy who were aged above 18 years and estimated glomerular filtration rate (GFR) less than 60 mL/min (calculated using CKD-EPI) with blood pressure less than 140/90 mmHg and hemoglobin more or equal 10 g/dL and normal coagulation parameter (PT and PTT)

排除标准

  • patients with history of venous thromboembolism (deep vein thrombosis or pulmonary embolism), history of breast cancer and endometrial cancer, abnormal vaginal bleeding, liver disease and/or history of coronary disease or cerebrovascular disease in previous 1 month before kidney biopsy

研究者

发起方
Kinh Chulalongkorn memorial hospital

相似试验

Transdermal Estrogen Provides Comparable... | 临床试验